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The prevalence of serious angiographic coronary artery disease 
ranges from 37% to 78% in patients undergoing operation for 
peripheral vascular disease. Clinical studies have demonstrated 
that cardiac outcome after peripheral vascular surgery is not 
adequately predicted by the standard criteria of history, physical 
findings and rest electrocardiogram. An adequate exercise work 
load, left ventricular function and thallium redistribution have 
proved important in perioperative risk stratification. The choice 
of a perioperative functional cardiac test depends on patient-
related factors and the nature of the peripheral vascular opera-
tion. Although procedures involving aortic cross-clamping exert a 
greater hemodynamic stress than do carotid endarterectomy and 
femoral popliteal surgery, late cardiac morbidity and mortality 
are significant in all patients with atherosclerotic disease. 
The management of patients with both coronary and periph-
eral vascular disease is difficult and raises many controver-
sial issues. What is the prevalence of coronary artery disease 
in the general population or in patients with occlusive 
vascular disease? What is the impact of an abnormal cardiac 
history or a positive stress test on peri operative risk and late 
outcome? Should stress testing be routinely performed be-
fore operation in all patients? To what extent do careful 
monitoring and intensive medical therapy decrease periop-
erative morbidity and mortality in high risk patients? What is 
the role of coronary artery bypass surgery or angioplasty in 
patients with peripheral vascular disease and when should it 
be performed? Answers to these important questions are not 
yet available and in the absence of definitive randomized 
trials of different management strategies, decisions must be 
based on extrapolation from data compiled primarily from 
individual reported series. Such data then need to be inter-
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The decision to proceed with preoperative coronary angiogra-
phy and myocardial revascularization should be based primarily 
on indications independent of the peripheral vascular procedure. 
However, peripheral vascular surgery may influence the timing of 
myocardial revascularization. Patients with high risk or unstable 
coronary artery disease may benefit from preoperative coronary 
revascularization, although this hypothesis remains unproved. In 
aU patients, careful monitoring during and after operation is 
essential. All patients with peripheral vascular disease should be 
considered to be at lifelong risk for fatal and nonfatal cardiac 
events and should undergo appropriate clinical and laboratory 
evaluation and be treated accordingly. 
(J Am Coll CardioI1991;18:203-14) 
preted within the framework of the results and experience of 
a specific physician or in a specific institution. 
Recent advances have extended the surgical correction of 
both coronary and peripheral vascular disease to older 
patients. Thus. the issue is of increasing importance as the 
population ages (1). Although old age itself should not be 
considered synonymous with coronary artery disease, the 
incidence of the latter increases strikingly in the elderly (2). 
Inevitably, we will be faced with a rapid expansion of a 
population in which the combination of advanced age and 
diffuse atherosclerosis will limit the potential for coronary or 
peripheral revascularization to alter long-term survival sig-
nificantly. Paradoxically, the development of newer imaging 
techniques has enabled the earlier recognition and treatment 
of peripheral vascular disease in younger patients (3,4). It is 
in this younger subgroup that the impact of coronary artery 
disease on late outcome is increasing in importance, as is the 
potential for coronary revascularization to improve out-
come. 
Prevalence of Coronary Artery Disease in 
Patients With Peripheral Vascular Disease 
An early Mayo Clinic study (5) in patients <60 years of 
age with "arteriosclerosis obliterans" seen between 1939 
and 1949 drew attention to the association between coronary 
and peripheral vascular disease. The collective reported 
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Figure 1. Prevalence of associated coronary artery disease in pa-
tients (Pts) with peripheral vascular disease. The data are from a 
review by Hertzer (6) of multiple series representing approximately 
10,000 patients. Stippled bars indicate 8,767 patients with "clinical" 
evidence of coronary artery disease; hatched bars represent 2,123 
patients with "serious" coronary artery disease on angiography. 
AAA = abnormal aortic aneurysm. 
experience was summarized recently by Hertzer (6) in a 
comprehensive analysis representing > 10,000 patients in 
approximately 50 series. Among patients with abdominal 
aortic aneurysms, carotid artery disease or lower limb ische-
mia, clinical evidence of coronary artery disease was present 
in approximately 50% (range 22% to 70% in individual series) 
(Fig. 1). The variation is due to mUltiple factors, including 
referral bias and changes in medical surveillance techniques 
for coronary artery disease over time and at different cen-
ters. 
Significant or "serious" coronary artery disease was 
present in approximately 60% of the patients undergoing 
angiography, although the definition of severity varied 
among the series (6). In a consecutive series (7) of 1,000 
patients at the Cleveland Clinic, among those without clini-
cal indications of coronary artery disease, the incidence of 
significant angiographic coronary disease (stenosis >70%) 
was as high as 37% compared with 78% in those with 
coronary artery disease suspected clinically. Moreover, 
among patients with significant angiographic coronary artery 
disease, multivessel disease was present in the majority 
(7-9). 
Impact of Coronary Artery Disease on 
Outcome After Peripheral Vascular Surgery 
Perioperative Outcome 
Perioperative mortality. Cardiac death (particularly fatal 
myocardial infarction) accounts for 40% to 60% of early 
postoperative deaths (6,10-14). The high mortality rate 
associated with postoperative myocardial infarction after 
noncardiac surgery was recognized by Master et al. (15) in 
1938. In patients with suspected coronary artery disease who 
undergo peripheral vascular surgery, the perioperative mor-
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Table 1. Mortality in Patients Undergoing Operation for 
Vascular Disease 
Operative 
Cardiac 
Mortality* 5 Year Mortalityt 
Status No. % No. % 
Overall 14,180 3.3 7,805 31 
No "overt" CAD 1,782 1.3 1,185 20 
Suspected CAD 1,337 6.8 1,092 41 
Prior CABG 1,237 1.5 1,172 21 
*Based on 29 reported series, representing 14,180 patients. tBased on 23 
reported series, representing 7,805 patients (53% of deaths were cardiac 
related). Data from Hertzer (6). CABG = coronary artery bypass grafting; 
CAD = coronary artery disease. 
tality rate is approximately four times higher than in those 
without coronary artery disease and perioperative morbidity 
is markedly increased (Table 1). In an analysis (6) of six 
series totaling approximately 4,500 patients, perioperative 
cardiac events occurred in 11 % (mean) of patients with 
clinical evidence of coronary artery disease and in only 1.7% 
of patients without it. In a population-based study (13) of 131 
patients undergoing elective abdominal aortic aneurysm 
repair between 1971 and 1987, perioperative complications 
occurred in 21% and 7% of patients with and without overt 
but stable cardiac disease, respectively. 
Carotid and peripheral vascular surgery versus abdominal 
aortic surgery. There is evidence to suggest that the sub-
stantial impact of coronary artery disease on perioperative 
outcome may not necessarily apply to a similar degree in 
patients undergoing carotid endarterectomy (a much less 
formidable surgical procedure) (6,16) or to the more contem-
porary experience with repair of abdominal aortic aneurysm 
(4,14,17-20). Similar data are not available for patients 
undergoing surgery for lower limb ischemia, but it is likely 
that the adverse effect of preoperative coronary artery 
disease on early outcome will be less in patients undergoing 
the more peripheral procedures (such as femoropopliteal 
reconstruction as opposed to aortoiliac reconstruction). 
However, in one large series (21), the perioperative event 
rate in patients undergoing peripheral vascular procedures 
exceeded that among patients undergoing aortofemoral by-
pass or abdominal aortic aneurysmectomy. 
Late Outcome 
Late mortality. Early natural history studies that ante-
date direct arterial reconstruction emphasized that the vast 
majority of deaths in patients with peripheral vascular dis-
ease were cardiac related. In the Mayo Clinic study (5) of 
patients with "arteriosclerosis obliterans" seen between 
1939 and 1949, late survival was worse for patients with 
aortoiliac disease than for those with femoropopliteal dis-
ease and the survival in both groups was markedly poorer 
than in an age- and gender-matched control group. In the 
longitudinal and prospective Whitehall study (22) of 18,388 
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civil servants in London, intermittent claudication was inde-
pendently related to late cardiovascular mortality. In a 
prospective population-based study (23) from the University 
of California-San Diego, a history of probable claudication 
doubled the risk of death. Even isolated small vessel periph-
eral arterial disease has been shown (24) to be an indepen-
dent risk factor for future cardiovascular events. 
More recent data highlight the important effect of coro-
nary artery disease on late mortality. Irrespective of the 
underlying peripheral vascular diagnosis, 40% to 60% of late 
deaths were cardiac related (6,14,25-32). Furthermore, late 
mortality is approximately twice as high in patients with 
"suspected" coronary artery disease as in patients without 
overt coronary artery disease (Table 1). This is reinforced by 
a Mayo Clinic study (32) of referral patients undergoing 
repair of abdominal aortic aneurysm. In the absence of 
hypertension or clinical cardiac disease, the observed 10-
year survival rate (54%) among 30-day surgical survivors 
was almost identical to that in age- and gender-matched 
control patients. 
Abdominal aortic aneurysm. In contrast, population-
based data from Olmsted County, Minnesota (13) strongly 
emphasize the markedly adverse impact of preexisting cor-
onary artery disease on the late outcome after abdominal 
aortic aneurysm repair. In perioperative survivors, the cu-
mulative incidence of cardiac events at 8 years was 61 % and 
15% for patients with and without suspected or overt coro-
nary artery disease, respectively. Moreover, the 8-year 
survival rate (59%) in patients without suspected coronary 
artery disease was only slightly less than that in an age- and 
gender-matched control population. This contrasts strikingly 
with the results in patients with suspected or overt heart 
disease-the 8-year survival rate was 34%, approximately 
half of that in age- and gender-matched control subjects 
(61%). By multivariate analysis, the presence of suspected 
but uncorrected coronary artery disease was associated with 
a nearly twofold increase in risk of death and a fourfold 
increase in risk of late cardiac events. Such data are partic-
ularly disturbing given that the symptoms among patients 
with suspected coronary artery disease were considered to 
be mild and stable to begin with. 
Changing technology has led to the earlier diagnosis of 
abdominal aortic aneurysm and the median size of clinically 
recognized aneurysms is decreasing (3). Because it is as-
sumed that rupture is less common with smaller aneurysms, 
the issue of coronary artery disease is important, particularly 
in younger patients in whom an abdominal aneurysm may be 
a marker of aggressive, "premature" vascular and coronary 
artery disease (3,4). This is relevant to the results of another 
Mayo Clinic study (14) in which survival after abdominal 
aortic aneurysm repair in a referral group was compared 
with survival in age- and gender-matched control subjects; 
the poorest relative survival (ratio of observed survival to 
survival in the control group) was in the youngest patients 
(those <60 years). 
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Carotid endarterectomy. Late overall mortality appears 
to be lower in perioperative survivors of carotid endarterec-
tomy than in patients who have undergone abdominal aortic 
aneurysmectomy or surgery for lower limb ischemia. None-
theless, a similar pattern is seen-preexisting clinical coro-
nary artery disease has a markedly detrimental influence on 
late survival (31,33). 
The impact of cardiac risk factors on late outcome after 
endarterectomy in patients without overt clinical heart dis-
ease was assessed in a recent large series (31). Over a 
15-year period, late mortality and rate of myocardial infarc-
tion were markedly less frequent in patients without the 
cardiac risk factors of diabetes, cigarette use or hyperlipi-
demia at the time of initial operation. This study emphasized 
the deleterious impact of overt coronary artery disease on 
survival and the influence of coronary artery risk factors in 
patients without "overt" coronary artery disease at presen-
tation. 
Lower limb surgery. In patients undergoing surgery for 
lower limb ischemia, late outcome is similarly related to the 
presence of coronary artery disease (11,34,35), diabetes 
mellitus (34) and diffuse distal occlusive disease (17,36-38). 
The association between diffuse distal occlusive disease and 
an adverse outcome suggests that this vascular disease may 
be a marker for more extensive coronary artery disease. 
Effect of Prior Coronary Artery Bypass 
Surgery on Prognosis 
During the last 20 years, several randomized trials and 
registry and data bank studies (39,40) have provided a wealth 
of comparative data on the efficacy of coronary artery 
bypass surgery and medical therapy in mUltiple subsets of 
patients with coronary artery disease. The results of these 
studies are remarkably consistent and the message is clear: 
the sicker the patient, as judged by severity of ischemia 
(41-43) or left ventricular dysfunction (39,43-45) and the 
number of diseased vessels (39-42), the greater the relative 
benefit of surgery over medical therapy (46). It is evident 
that many patients with peripheral vascular disease are in a 
high risk category and, as SUCh', are candidates for coronary 
revascularization. In the multicenter randomized European 
Coronary Surgery Study (47), the 8-year survival benefit of 
surgery over medical therapy was substantially greater in 
patients in whom peripheral vascular disease was present 
(85% vs. 52% survival rate) than in patients without vascular 
disease (90% vs. 81% survival rate). What is noteworthy is 
the particularly poor 8-year survival rate (only 52%) with 
medical therapy in patients with peripheral vascular disease. 
Risk of Non cardia c Surgery After Coronary 
Bypass Surgery 
Operative mortality. There is evidence from nonrandom-
ized studies (9,11,13,48-54) to suggest that the risk of 
noncardiac surgery is low after prior coronary artery bypass 
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surgery. In the Coronary Artery Surgery Study (CASS) 
Registry (54), the mortality and morbidity rates for non car-
diac surgical procedures in patients who had had prior 
coronary artery bypass surgery were similar to those in 
patients without significant coronary artery disease on angi-
ography. In patients undergoing vascular surgical proce-
dures, the mean operative mortality rate in seven series (6) 
totaling 1,237 patients was only 1.5% among patients with 
prior coronary artery bypass surgery, similar to the 1.3% 
mortality rate in patients without overt coronary artery 
disease and substantially lower than the 6.8% mortality rate 
in patients with suspected but uncorrected coronary artery 
disease (Table 1). 
Late mortality after vascular surgery. This also appears 
to be lower in patients who have undergone prior coronary 
artery bypass surgery (6,14). The 5-year mortality rate 
estimated from the overview by Hertzer (6) was 21% in 
patients with prior coronary artery bypass surgery, 20% in 
patients without" overt" coronary artery disease and 41 % in 
patients with suspected coronary artery disease but no prior 
revascularization (Table 1). In the Cleveland Clinic experi-
ence (25,51) in 216 patients with peripheral vascular disease 
and "severe, correctable" coronary artery disease, 5-year 
survival appeared to be substantially enhanced by prior 
coronary artery bypass surgery, particularly in men and 
nondiabetic patients. 
Effect of peripheral vascular disease on coronary bypass 
operative mortality. The protective shield of prior coronary 
artery bypass surgery has a price. The mean age of patients 
undergoing vascular surgery is approximately 65 years. In 
the CASS Registry (55), the operative mortality rate was 
5.2% in patients :::::65 years old and 1.9% in patients <65 
years old. In the more contemporary Cleveland Clinic expe-
rience (56), the operative mortality rate was 0.7%, 2% and 
4.7% in patients aged <65, 65 to 74 and :::::75 years, respec-
tively. In a recent Mayo Clinic series (57), after isolated 
coronary artery bypass surgery in 159 octogenarians, the 
peri operative mortality rate was 10.7%; it was 4% in patients 
without other medical conditions and 14.8% and 16.7% in 
patients with cerebrovascular and peripheral vascular dis-
ease, respectively. Furthermore, at the Cleveland Clinic (7) 
between 1978 and 1983, the operative mortality rate after 
isolated coronary artery bypass surgery in patients with 
peripheral vascular disease was 5%. Even among a younger 
group of patients, approximately 2,500 patients in the CASS 
Registry with stable angina (of whom only 11 % were >65 
years old), the peri operative mortality rate in those with 
noncardiac vascular disease was 3.3% (CASS, unpublished 
data). 
The late outcome after coronary artery bypass surgery is 
also less favorable in patients with peripheral vascular 
disease (39). In both the CASS Registry and the Duke 
experience (39), the presence of noncardiac vascular disease 
was an independent predictor of late mortality (Table 2). In 
the Duke experience (39), the 8-year survival rate was 82% 
in patients without and 69% in patients with noncardiac 
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Table 2. Effect of Noncardiac Vascular Disease on Survival After 
Coronary Artery Bypass Surgery 
Survival (%)* 
Overall Event-free 
Vascular dIsease Present Absent Present Absent 
CASS 
Mild angina 68 86 49 58 
Severe angina 71 83 45 58 
Duke series 69 82 65 73 
'Six years In the Coronary Artery Surgery Study (CASS) and 8 years in 
the Duke series. Data from Gersh et al. (39). 
vascular disease. In the CASS Registry (39), the presence 
of noncardiac vascular disease also was a relatively 
powerful predictor of late cardiac events in addition to 
survival (Table 2). 
Role of prior coronary angioplasty. Very few data are 
available on the effect of prior coronary angioplasty on the 
outcome of noncardiac surgical procedures. At our institu-
tion (58), 50 patients with severe coronary artery disease 
underwent 54 non cardiac surgical operations (approximately 
50% were peripheral vascular procedures) at a mean of 9 
days after coronary angioplasty. Despite a high incidence of 
severe symptoms and markedly positive stress tests before 
angioplasty, there were only one death and two nonfatal 
infarctions during the perioperative period, for a total event 
rate of 5.3%. To what extent coronary angioplasty will be 
applicable to patients with peripheral vascular disease, of 
whom many have diffuse multivessel disease, remains to be 
seen. 
Summary. The presence of peripheral vascular disease 
suggests that a patient is in a subset with high risk coronary 
artery disease. In such patients, the potential benefit from 
coronary artery bypass surgery (particularly with regard to 
survival) is enhanced and the desirability of prior revascu-
larization is readily understandable (39,43,44,46,47). None-
theless, it must also be accepted that perioperative mortality 
and morbidity after coronary bypass surgery are increased in 
these patients. Although this is primarily a function of age, 
the presence of peripheral vascular disease is an important 
and independent determinant of a poorer late outcome after 
bypass surgery, even though this outcome may be substan-
tially better than that obtained with medical therapy alone. 
Preoperative Evaluation 
Meticulous preoperative evaluation with attention to con-
comitant medical conditions is a crucial part of the manage-
ment of the patient who is to undergo vascular surgery. The 
immediate objective is to identify high risk patients who will 
need careful cardiac surveillance and monitoring (before, 
during and after operation), prior coronary artery revascu-
larization or combined coronary and peripheral vascular 
procedures. It also is important to identify the factors that 
determine late prognosis and management. 
JACC Vol. 18, No. I 
July 1991:203-14 
Clinical Evaluation 
Preoperative risk factors. In a comprehensive recent re-
view, Mangano (52) discussed the impact of the traditional 
risk factors on the outcome of noncardiac surgery. Whereas 
few would dispute that recent prior myocardial infarction 
(59-62), age (63) and congestive heart failure (63,64) are 
established preoperative risk factors, the role of other fac-
tors such as hypertension, a history of angina pectoris, 
diabetes, ventricular extrasystoles and an abnormal 12-lead 
electrocardiogram (ECG) is more controversial (52,65). Dif-
ferences in the patient groups included in multiple studies 
that span 35 years, during which there have been profound 
changes in medical, anesthetic and surgical management, 
undoubtedly account for many of the discrepancies among 
the published series (52). 
A systematic and laudable approach to the preoperative 
evaluation of patients undergoing noncardiac surgical 
procedures was developed by Goldman et al. (63) in 1977. 
Although their multifactorial cardiac risk index has been 
validated prospectively (66), it probably underestimates 
perioperative risk in patients undergoing vascular surgery, 
who frequently have concomitant coronary artery disease 
(67,68). Only 16% of the patients studied by Goldman et al. 
(63) underwent aortic or peripheral vascular surgery, only 
27% had clinical evidence of coronary artery disease and 
only 7% had a history of prior myocardial infarction or 
angina. Therefore, it is not surprising that Goldman et al. 
did not find stable angina to be a significant predictor of 
outcome. Consequently, neither the presence nor the sever-
ity of angina pectoris is taken into account in their calcula-
tion of the risk score, although these factors were incorpo-
rated into a modified cardiac risk index by Detsky et al. 
(69,70). 
Left ventricular function. The lack of quantitative mea-
surements of left ventricular function is another limitation of 
the preoperative cardiac risk indexes developed in the 1970s. 
Clinical evidence of prior congestive heart failure undoubt-
edly identifies patients at very high risk (64), but interob-
server agreement over the presence or absence of the 
standard clinical signs of heart failure (S3 gallop, distended 
neck veins and pulmonary rales) is disappointingly poor, as 
is the correlation between clinical signs and measurement of 
ejection fraction (Fig. 2) (71). In another prospective study 
(72) of patients with chronic heart failure, the combination of 
rales, edema and distended neck veins was highly specific 
for pulmonary capillary wedge pressure ;:::22 mm Hg, but the 
sensitivity was only 58%. 
These data do not diminish the importance of a careful 
initial clinical evaluation in addition to routine laboratory 
testing. However, in high risk patients such as those under-
going vascular surgery, in whom underlying cardiac disease 
has a substantial impact on both early and late outcome, the 
additional prognostic information provided by stress testing 
is needed. 
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Figure 2. Correlation between physical signs of congestive heart 
failure and left ventricular ejection fraction (L VEF) in patients with 
myocardial infarction. Relatively few patients had two or more 
physical signs of cardiac failure. In the majority who had no or one 
physical finding, the correlation with ejection fraction was poor. The 
shaded area represents the normal range of ejection fraction. (From 
Gadsb~ll et al. [71], with permission of the European Society of 
Cardiology. ) 
Laboratory Evaluation 
Rest and exercise electrocardiography. In adult patients, 
the 12-lead ECG is almost universally recorded during the 
preoperative period. Despite its common use, few prospec-
tive studies evaluating either the efficacy or the cost-
effectiveness of a routine preoperative ECG have been 
reported. In a strict multivariate analysis of 200 patients 
undergoing elective noncardiac surgery, Carliner et al. (73) 
found an abnormal rest ECG (defined as ST-T wave abnor-
malities, left ventricular hypertrophy or the presence of Q 
waves) to be the only independent predictor of postoperative 
cardiac events. However, others (64,74) have not repro-
duced these results. 
In patients requiring vascular surgery, up to 35% of 
patients with a normal rest 12-lead ECG will have an 
abnormal exercise ECG and some will have postoperative 
cardiac ischemic events (75,76). These data support the view 
that although the 12-lead ECG may be useful for screening 
general surgery patients, functional cardiac testing is neces-
sary for adequate risk stratification in higher risk patients 
with peripheral vascular disease. 
Treadmill exercise test. The feasibility of treadmill exer-
cise testing has been examined in patients undergoing gen-
eral (73) and vascular (75,77,78) surgery. Clearly, treadmill 
exercise testing will not be suitable in patients who have 
severe claudication or rest ischemia or an amputated limb. In 
patients with a lesser degree of claudication who undergo 
treadmill exercise testing, careful attention to target achieve-
ment (percent functional aerobic capacity or maximal heart 
rate) is needed. In one study (75), 45 of 130 patients 
undergoing peripheral revascularization were unable to 
achieve a target heart rate for noncardiac reasons. Such 
patients continued to have an undefined risk of perioperative 
myocardial infarction and remained susceptible to perioper-
ative ischemic episodes (75). 
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Table 3. Predictive Value of Reversible Defects (Redistribution) on Dipyridamole Thallium-201 Imaging for Perioperative Events 
Cardiac Events 
With Redistribution With Normal Scans or Fixed Defects 
Source Events NO.ofPts % Events No. of Pts % Event 
Boucher et al. (91) 8 16 50 0 32 0 MI and unstable angina 
Sachs et aI. (92) 3 14 21 0 32 0 MI and unstable angina 
Fletcher et al. (93) 2 67 0 14 0 MI 
Leppo et al. (94) 14 53 26 47 2 MI 
Eagle et al. (95) 25 82 30 5 118 4 MI and unstable angina 
Lapeyre et al. (%) 9 46 20 1 69 1 MI 
Total* 61 214 28 7 312 2 
*Predictive values: positive 28%; negative 98%. MI = myocardial infarction; Pts = patients. 
Both the ability to reach an adequate exercise work load 
and the ECG response to treadmill exercise testing have 
been important in identifying patients at high or low risk of 
perioperative cardiac events (75,77,78). Thirty-five patients 
who achieved> 75% of maximal predicted heart rate and had 
a normal exercise ECG had no perioperative myocardial 
infarction (75). However, patients with clearly abnormal 
treadmill exercise test results had a 16% incidence of peri-
operative myocardial infarction. Furthermore, among 27 
high risk patients (positive ECG at low work load), 7 had a 
perioperative myocardial infarction, which was fatal in 5. 
Similar successful risk stratification in patients undergoing 
vascular surgery was reported in a European series (77), but 
these results have not been generalizable to patients under-
going general surgery, which may reflect a lesser prevalence 
of severe coronary artery disease in the latter patients (73). 
Radionuclide angiography: role of left ventricular function. 
In a retrospective review (79) of 100 patients undergoing 
lower limb revascularization, radionuclide angiography at 
rest was found to accurately predict the risk of perioperative 
myocardial infarction. On the basis of ejection fraction 
criteria, incremental increases in the incidence of perioper-
ative myocardial infarction were noted: 0% if ejection frac-
tion was >56%, 19% if it was 36% to 55% and 75% if it was 
<36%. Additionally, radio nuclide angiography has been 
useful in making the decision to perform preoperative coro-
nary angiography and coronary artery bypass surgery (53). 
Nonetheless, others (68,74,80-82) have not confirmed the 
predictive utility of the preoperative left ventricular ejection 
fraction at rest in patients undergoing abdominal aortic 
aneurysm repair. In one study (80) despite an overall peri-
operative myocardial infarction rate of 7%, stratification of 
patients on the basis of ejection fraction alone also failed to 
identify patients with peri operative infarction, although an 
ejection fraction of <35% was associated with a significantly 
poorer long-term outcome. 
In a Mayo Clinic study (81) of the clinical utility of supine 
exercise radionuclide angiography in 114 patients undergo-
ing peripheral vascular surgery, eight perioperative cardiac 
events occurred in the subgroup of 63 patients unable to 
achieve a work load of 400 kg·m/min (4.5 METs for a 
70 kg person). Multiple other variables including rest ejec-
tion fraction and ejection fraction response to exercise failed 
to predict perioperative events independently. Similar find-
ings were noted in another study (74) of patients >65 years 
old undergoing noncardiac (although not necessarily vascu-
lar) surgery, emphasizing the importance of a functional 
limitation due to ischemia as opposed to rest left ventricular 
function alone in the prediction of perioperative events 
(68,82). 
Dipyridamole thallium-20t scintigraphy. Intravenous 
dipyridamole thallium-20l scintigraphy has provided an im-
portant addition to the prognostic capability of nuclear 
imaging. In patients unable to exercise adequately, intrave-
nous infusion of dipyridamole at 0.56 mg/kg (the usual dose 
in clinical studies) causes a significant increase in coronary 
blood flow in regions perfused by normal coronary arteries 
but only a minimal increase in zones sub served by a stenotic 
vessel (83,84). The ability to detect regions of abnormal 
coronary flow reserve in patients unable to exercise has 
focused considerable attention on the technique and the risk 
stratification of patients undergoing peripheral vascular sur-
gery (85-89). The technique is safe; there were only 10 major 
adverse events (including 2 fatal and 2 nonfatal myocardial 
infarctions) in a recent series of 3,911 cases (90). Side 
effects, including bronchospasm, chest pain and dizziness, 
are frequent and the 4.6% incidence of hypotension man-
dates caution, particularly in patients with carotid artery 
disease. It was reassuring, however, that in nearly all 
patients, intravenous administration of aminophylline 
promptly relieved symptoms (90). 
In 1985, Boucher et al. (91) reported on 48 patients who 
underwent dipyridamole thallium-20l imaging before periph-
eral vascular surgery. Eight of the 16 patients with thallium 
redistribution (indicative of underperfused but viable myo-
cardium on planar imaging) had significant perioperative 
cardiac ischemic events (Table 3) (91-96). In contrast, none 
of the 32 patients with either a normal scan or a fixed 
perfusion deficit (generally indicating prior myocardial in-
farction but no concomitant active ischemia) had a cardiac 
event in the postoperative period. Six other patients who had 
a thallium-20l redistribution defect underwent coronary 
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angiography, which confirmed severe multivessel disease in 
all patients. In this study, the only clinical or scintigraphic 
independent predictor of postoperative cardiac events was 
the presence of a thallium-20l redistribution defect. 
The prognostic capability of dipyridamole thallium-201 
scintigraphy can be extended to many different subsets of 
patients with coronary artery disease (Table 3) (97). Pooled 
data from several studies (76,91-96) illustrate that the tech-
nique is highly sensitive (90% [61 of 68 patients]) but only 
moderately specific (59% [305 of 519 patients]) in the pre-
operative evaluation of vascular surgery patients (Table 3). 
The positive predictive accuracy of dipyridamole thallium-
201 scanning is enhanced by semiquantitative techniques 
aimed at assessing the extent of thallium redistribution 
(98,99). 
In an attempt to place the dipyridamole thallium study 
into clinical perspective, Eagle et al. (95) combined the 
prognostic information from scintigraphy with important 
clinical predictors of events-namely, Q waves on the ECG, 
history of premature ventricular extrasystoles, diabetes, 
advanced age and angina pectoris. Preoperative imaging was 
most useful in predicting outcome in those patients consid-
ered to be at intermediate risk on the basis of one or two 
clinical predictors, whereas among those with no risk fac-
tors, the event rate was extremely low (3.1 %) irrespective of 
the scintigraphic findings. In contrast, the 20 patients at high 
risk (three or more risk factors) had an event rate of 50%, 
and this rate did not differ significantly between those with or 
without a redistribution defect. Two other studies (100,101) 
in which a fixed defect was considered to be synonymous 
with a reversible defect also implied that dipyridamole 
thallium-201 imaging was less useful in patients considered 
to be at low risk. However, other investigators (94,102-104) 
noted that scintigraphic variables were superior to clinical 
factors in predicting events in their entire patient groups. 
Despite the data presented in Table 3, the presence of a 
fixed defect at 4-h imaging should not necessarily lull one 
into a false sense of security. McEnroe et al. (68) reported a 
high (47%) perioperative cardiac event rate among 15 pa-
tients undergoing vascular surgery who had a fixed defect at 
4-h imaging. This finding is not surprising. There is an 
accumulating body of evidence (105-111) that 15% to 20% of 
apparently fixed defects on thallium scans at 4 h may 
represent viable myocardium as determined by more sensi-
tive imaging techniques. However, despite these disparities 
in segmental analyses, the great majority of individual pa-
tients are correctly categorized as having ischemic myocar-
dium in one or more other areas. All of these imaging 
techniques are promising and include computed positron 
emission tomography (105), late redistribution imaging 
within 18 to 72 h (106), single photon emission computed 
tomography (107-109), quantitative analysis of thallium ki-
netics (112) and imaging with a second injection of thallium-
201 given after the initial redistribution images are recorded 
(110,111). It is likely that the use of these methods will 
enhance the predictive ability of stress testing in patients 
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being considered for vascular surgery, but this remains to be 
determined in studies in larger numbers of patients. 
Recent evidence has drawn attention to the value of 
dipyridamole thallium-20l scintigraphy for late prognosis. 
In a large series (99) in which survivors of elective vascular 
surgery were followed up for a mean of 32.5 months, the 
strongest factor predicting late cardiac death or events was 
the presence of a fixed defect on dipyridamole thallium 
scintigraphy. 
Ambulatory ECG monitoring. Raby et al. (113) use 24- to 
48-h Holter ECG monitoring to evaluate prospectively 176 
consecutive patients undergoing vascular surgery. ST seg-
ment depression of 1 mm occurring 60 ms after the J point 
and persisting for 2:60 s was considered to be evidence of 
preoperative myocardial ischemia. Of the 32 patients with 
such ischemic episodes, 12 had significant postoperative 
cardiac events. In contrast, only 1 of the 144 patients with no 
preoperative ischemia had a postoperative cardiac event. In 
a multivariate analysis (113), preoperative ischemia was the 
most powerful predictor of postoperative ischemia (relative 
risk 24.4; 95% confidence interval 6.8 to 88; sensitivity 92%; 
specificity 88%). A much smaller study (114) using shorter 
periods of preoperative monitoring produced similar find-
ings. These preliminary but promising data warrant further 
evaluation, but the technique is limited to patients without 
repolarization abnormalities on the rest ECG. 
A recent important study (115) of 474 patients with or at 
high risk of coronary artery disease undergoing noncardiac 
surgery assessed the importance of myocardial ischemia by 
continuous ECG monitoring, beginning 2 days before sur-
gery and continuing for 2 days thereafter. The greatest 
frequency of myocardial ischemia occurred during the post-
operative period (41% of episodes) compared with 20% 
preoperatively and 25% intraoperatively. In a multivariate 
analysis (115), early postoperative ischemia was the most 
important correlate of all adverse cardiac outcomes (2.8-fold 
increase) and of a cardiac ischemic event (9.2-fold increase). 
Moreover, in another large study (116), ambulatory ECG 
monitoring for myocardial ischemia was shown to be a 
significant independent predictor of 1- to 2-year prognosis as 
opposed to perioperative outcome alone. 
Other techniques under development that have potential 
applicability include thallium scintigraphy with atrial pacing 
(117), dobutamine echocardiography (118) and the use of 
adenosine in place of dipyridamole in thallium scintigraphy. 
Comment. The choice of a functional cardiac test in 
patients undergoing vascular surgery may be very complex. 
Test applicability for an individual patient will be contingent 
on the severity of cardiac symptoms, ability to ambulate, 
associated medical and surgical conditions, baseline ECG 
abnormalities and institutional expertise with specific diag-
nostic techniques. Knowledge of the test's positive and 
negative predictive values in patients selected to undergo 
vascular surgery is crucial. Ideally, the perfect test would 
include an assessment of both myocardial perfusion and left 
ventricular function, but the appropriate test or tests actually 
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Figure 3. Preoperative hemodynamics in 130 patients undergoing 
elective abdominal aortic surgery. "High risk" refers to patients 
with a preoperative history of cardiac disease or hypertension. The 
shaded area represents the normal range of left ventricular function. 
Only 20% of high risk patients (solid circles) were within the normal 
limits of the curve compared with 70% of low risk patients (open 
circles). LVSWI = left ventricular stroke work index; PAo = 
pulmonary artery occluded pressure. (From Cohen et al. [18], with 
permission of Reed Publishing USA.) 
performed should be chosen only after careful consideration 
of all of these factors. 
Management Strategies 
A standardized approach to the high risk patient cannot 
be advocated at this time. Moreover, the absence of defini-
tive data from randomized trials must be emphasized. 
Clearly, a policy of routine prophylactic coronary revascu-
larization before vascular surgery is impractical and could be 
dangerous. Moreover, in the current era, it is evident that 
patients with serious cardiac disease can undergo extensive 
vascular procedures with relative safety, albeit at an in-
creased risk. The preoperative identification of high risk 
patients is crucial. Intensive medical therapy with monitor-
ing can stabilize the patient preoperatively, potential intra-
operative problems can be anticipated and during the post-
operative period, careful hemodynamic monitoring and 
continued cardiac surveillance are mandatory. 
Perioperative hemodynamic monitoring. Although there 
are no definitive data to substantiate the role of hemody-
namic monitoring, its use is logical, clinical impressions are 
favorable and several series (18,19,62) have documented low 
morbidity and mortality in high risk patient subsets. Preoper-
ative invasive monitoring has revealed that some patients 
have significant hemodynamic derangements; in these, cor-
rection of hypovolemia or cardiac failure is likely to be 
beneficial (Fig. 3) (18,19,119,120). Moreover, major vascular 
procedures are associated with extensive and labile hemo-
dynamic fluctuations during aortic cross-clamping, aortic 
declamping, hemorrhage, transfusion, fluid shifts due to 
sequestration and mobilization. Most would agree that in 
this setting, the careful use of invasive monitoring outweighs 
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the potential risks (18,19,121). Of emerging interest are 
technologies aimed at the detection of transient myocardial 
ischemia during the perioperative period. These include ST 
segment monitoring (122,123), transesophageal echocardiog-
raphy (122,124) and radionuclide monitoring of left ventric-
ular function (125). In patients undergoing coronary artery 
bypass surgery, the development of wall motion abnormali-
ties on transesophageal echocardiography is more sensitive 
than the ECG as an indicator of ischemia (122). 
Indications for Coronary 
Artery Revascularization 
The decision as to which patient should undergo coronary 
revascularization in addition to vascular surgery depends on 
many factors, including age, the presence and severity of 
other medical conditions, the severity of ischemia, the 
number of diseased coronary arteries and the degree of left 
ventricular dysfunction. Consideration for vascular surgery 
alone is not an indicationfor coronary revascularization, but 
its timing may be influenced by the nature of the intended 
vascular procedure. More limited procedures-for example, 
carotid endarterectomy and femoropopliteal reconstruc-
tion-can be accomplished with minimal morbidity in the 
stable cardiac patient, provided that careful attention is 
given during the preoperative and perioperative periods. 
Consequently, if clinically indicated, coronary revascular-
ization can be performed later after vascular surgery. 
Conversely, although more extensive procedures-for 
example, abdominal aortic aneurysm repair or aortoiliac 
reconstruction-can be performed with relative safety in a 
cardiac patient, perioperative morbidity is increased com-
pared with that associated with minor procedures. With this 
in mind, if it has already been decided that a patient is a 
candidate for coronary revascularization, it appears to be 
reasonable to perform this first and to perform the elective 
vascular procedure at a later date. 
Approaches 
Patient without overt heart disease. In the ambulatory 
patient without overt heart disease, perioperative morbidity 
and mortality are very low, particularly in nondiabetic 
patients <70 years old (95). The bulk of the available data 
(82,95,100,101) suggest that preoperative stress testing is not 
necessary in all patients (specifically not in those at low risk) 
if the sole objective of the test is to evaluate perioperative 
risk. Nonetheless, the powerful impact of coronary artery 
disease on late prognosis and its close association with 
peripheral vascular disease (even among patients without 
clinically suspected coronary artery disease) reinforce the 
role of stress testing at some time in the patient's course, 
even if during the period of convalescence (82). In this 
setting, the stress test provides important prognostic infor-
mation in addition to serving as a baseline for comparisons at 
regular intervals during follow-up study (82). 
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Many patients with peripheral vascular disease are rela-
tively inactive, which may mask the presence of sympto-
matic coronary artery disease. Despite the apparent absence 
of overt heart disease in these patients, preoperative stress 
testing using dipyridamole thallium-201 or Holter ECG mon-
itoring is indicated. Subsequent management should be 
dictated by the results of the stress test and will involve the 
decision to perform angiography with a view toward coro-
nary revascularization as opposed to proceeding directly to 
vascular surgery with or without intensive pre- and periop-
erative monitoring. 
Patients with overt "stable" coronary artery disease. A 
strong case can be made for preoperative stress testing in all 
patients with stable coronary artery disease and abdominal 
aortic aneurysm or lower limb ischemia. In patients with a 
significantly positive test, preoperative coronary angiogra-
phy and, if necessary, coronary revascularization are indi-
cated. Both stress testing and coronary angiography may 
identify subsets of patients in whom coronary revasculariza-
tion is not needed, but in whom potential perioperative 
problems can be anticipated and perhaps prevented by 
optimization of medical therapy and intensive monitoring. 
Patients with carotid artery disease should be ap-
proached differently because the development of exercise-
induced hypotension (which may be particularly dangerous 
in the presence of a severe carotid stenosis) is increased in 
patients with significant coronary artery disease. Further-
more, perioperative morbidity and mortality after coronary 
endarterectomy appear to be lower in patients with stable 
coronary artery disease than after more extensive proce-
dures on the abdominal aorta. Consequently, in patients who 
have coronary artery disease considered to be stable and 
who are to undergo carotid endarterectomy, preoperative 
stress testing can be avoided but should be performed before 
hospital discharge because the impact of coronary artery 
disease on the long-term outcome after carotid endarterec-
tomy is substantial. 
Patient with unstable or severely symptomatic coronary 
artery disease. Patients with an unstable coronary artery 
syndrome or those with severe ischemic and peripheral 
vascular disease can be categorized into two subgroups 
according to the stability or instability of the peripheral 
vascular disease. In those being considered for an "elec-
tive" vascular procedure, the first step is to stabilize the 
cardiac symptoms. This is followed by angiography with a 
view toward coronary revascularization. In some patients, 
the approach is dependent in part on the clinical indications 
for vascular surgery, and the most prudent option may be to 
defer or cancel the vascular procedure entirely. In others in 
whom coronary revascularization is performed, this should 
be followed by a "staged" vascular repair, either during the 
same hospitalization or at a later date, dependent in part on 
the underlying vascular diagnosis (126). In the relatively few 
patients with both unstable coronary and peripheral vascular 
disease, a combined procedure will be necessary. 
GERSH ET AL. 211 
PERIPHERAL AND CORONARY VASCULAR DISEASE 
Conclusions 
There is a close association between coronary and periph-
eral vascular disease and the evaluation and management of 
such patients are complex. Undoubtedly, the presence of 
coronary artery disease in patients undergoing peripheral 
vascular surgery identifies those at high risk with regard to 
both early and late outcome. In certain subgroups of pa-
tients, coronary revascularization is likely to improve the 
outcome, but the mortality rate after coronary artery bypass 
surgery is increased and the long-term outcome is not as 
good as in patients without peripheral vascular disease. 
Definitive guidelines for the management of patients with 
combined coronary and vascular disease are not available, 
but it is becoming increasingly apparent that stress testing 
plays an important role in most subsets of patients. 
The key to successful peripheral vascular surgery is a 
close collaboration among the cardiologist, vascular sur-
geon, anesthesiologist and, for many patients, the cardiac 
surgeon. Because atherosclerosis is a progressive disease 
and the association between coronary and peripheral vascu-
lar disease is strong, the ~nteraction between the cardiologist 
and the vascular surgeon should continue after the patient is 
discharged from the hospital and during subsequent postop-
erative evaluations. 
We thank Jeffrey A. Leppo, MD, University of Massachusetts, Worcester, 
and Kim A. Eagle, MD, Massachusetts General Hospital, Boston, Massachu-
setts for their constructive criticism. 
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